| Literature DB >> 19563632 |
Kinga Bágyi1, Angela Haczku, Ildikó Márton, Judit Szabó, Attila Gáspár, Melinda Andrási, Imre Varga, Judit Tóth, Almos Klekner.
Abstract
BACKGROUND: Post-operative pulmonary infection often appears to result from aspiration of pathogens colonizing the oral cavity. It was hypothesized that impaired periodontal status and pathogenic oral bacteria significantly contribute to development of aspiration pneumonia following neurosurgical operations. Further, the prophylactic effects of a single dose preoperative cefazolin on the oral bacteria were investigated.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19563632 PMCID: PMC2709628 DOI: 10.1186/1471-2334-9-104
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Figure 1Clinical parameters of patients. Patients that developed pneumonia had comparable age, weight and duration of operation to controls that had no postoperative pneumonia. (A): Patients demographic data in a table format. (B-C): The patients who developed postoperative pneumonia were matched according to sex, age, weight and length of brain surgery. Data were compared using the non-parametric Mann-Whitney test and expressed as "box and whiskers: 10–90 percentile".
Figure 2Relative risk for postoperative pneumonia in relation to periodontal diseases. Presence of periodontal diseases and disease severity were significantly greater in patients with postoperative pneumonia. (A-B): Data were expressed as "box and whiskers: 10–90 percentile" and compared using the non-parametric Mann-Whitney test (A): Disease score: periodontal diseases in every patient were evaluated. A score number was ordered to each diagnose, and the sum of the scores appears as "disease score". * = p = 0.0018 (B): Severity score is the number of co-existing periodontal diseases in each patient. * = p = 0.031; (C): Analysis of Relative Risk: "High score" patients had a Disease Score of ≥ 15 and a Severity Score of ≥ 3. Number of patients is shown in each groups. Chi-square test was performed, one-sided p value was calculated. *p < 0.0001; Relative risk: 3.5; confidence interval (95%): 1.085 to 11.29.
Figure 3Minimal inhibitory concentrations (MIC) of cefazolin and its concentration in serum. Neither cefazolin sensitivity of the bacteria isolated from the saliva/bronchial secretions nor serum cefazolin levels were different between control and pneumonia patients. Bacteria were isolated from the saliva pre- and postoperatively. Bronchial secretion and serum were obtained post-operatively for bacterial culture and determination of cefazolin levels. (A): Distribution of isolated bacteria according to their MIC values. The antibiotic level of all the saliva and bronchial secretion samples fell below 0.5 mg/L; marked by the vertical dashed line. (B): Distribution of isolated bacteria according to percentage of patients with that particular species in each group. (C): Serum cefazolin levels are expressed as "box and whiskers: 10–90 percentile" and compared using the non-parametric Mann-Whitney test between control and pneumonia patients (n = 18 and 5, respectively).
Figure 4Comparison of the minimal inhibitory concentration (MIC) of cefazolin regarding the bacteria isolated preoperatively from the saliva and postoperatively from the sputum. Cefazolin resistant pathogenic, Gram negative bacteria isolated from the saliva pre-operatively, were also grown from the sputum of the postoperative pneumonia patients. The vertical axis of the graphs crosses the x axis at 0.5 mg/L. The antibiotic level of all the sputum samples fell below 0.5 mg/ml. The bars indicate the MIC value of bacteria obtained pre-operative from the saliva. Black bars denote the bacteria that were cultured from both the sputum and the saliva of the same patient.